Scott DeFoe

Experience

• 

  Medtronic

  Feb 2000 - Jun 2023

  Strengthened business growth by driving novel new technology-enabled Business Development Program to identify high-potential early-stage opportunities and eliminate barriers preventing commercialization of innovative solutions to key unmet medical needs.• Led robust global innovation-minded opportunity identification, assessment, and ExCom-level informed decision-making process.• Synthesized pan-operating unit and cross-functional subject matter expertise to activate complex and latent enterprise potential.• Engaged Strategy and new Business Development executives across operating units to maximize value creation by prioritizing high-impact opportunities and accelerating commercialization utilizing distinct financing framework to secure VC and PE funding.• Partnered with incubator to establish serial start-up pipeline and build diversified new business opportunity portfolio. Worked with start-up CEO and Board of Directors to rapidly staff programs, accelerate time-to-market, and quickly mitigate risk. Show less As Chief of Staff, led strategy, operations and key enterprise programs for Senior Vice President with global responsibility for Clinical Research, Science & Technology, Data Science & AI, Regulatory, Medical Safety, and Health Economics & Reimbursement.• Planned and conducted Quarterly Business Reviews with CEO and Executive Committee, and vital topics for the Board of Directors.• Devised and executed strategic planning, performance management, and program governance to deliver strong alignment across complex global functions with a direct budget of $100M+, succeeded autonomously and by collaborating with senior executives.• Lead Clinical Research strategic planning and managed programs to advance best practices and IT systems that delivered cost reductions across global clinical study portfolio and reduced a decade-long enterprise-wide growth rate of 15% to 3%.• Championed strategic initiatives in Enterprise Excellence, Medical Safety, Compliance, Ethics, and Enterprise Risk Management, including functional integration of the largest acquisition in MedTech history while capturing $100M+ in operational savings. Show less Led New Therapies & Diagnostics business strategy and planning team of 11, secured commitment to commercialize breakthrough technologies that ultimately dominated mature cardiac markets including deeply miniaturized pacemaker and cardiac monitor.• Managed $6B Operating Unit’s Product Strategy Board, overseeing strategic plan and annual operating budget decision-making. • Established and administered product development incubator phase gate governance from concept feasibility to market release.• Dramatically improved market research best practices by deftly blending traditional KOL Advisory Boards, large-scale third-party market research, and novel new procedure-centric collaboration in hospitals and pre-clinical laboratory. Leveraged robust voice of the customer market research techniques to prioritize business opportunities, develop requirements, and direct global strategy.• Conceived and executed innovative new pre-clinical interventional advisory board format capturing the vital importance of representative hands-on concept assessment to validate strategies and drive alignment across product development core teams.• As the first planner to focus upon Heart Failure Therapy implant procedure, became instrumental in driving sales growth and profitability for revolutionary new therapy that achieved $1B in revenue faster than any prior implantable device. Employed insight rich ethnographic techniques to identify unmet needs while visiting hundreds of hospitals in 30+ countries. Show less

  • Sr Program Director | Strategic Innovation | Enterprise-wide Business Development

    Sept 2020 - Jun 2023

  • Sr Program Director | Chief of Staff | Clinical, Regulatory, Economics, Safety, Science & Technology

    May 2012 - Sept 2020

  • Marketing Director | Strategic Planning & Portfolio Management | Cardiac Operating Unit

    Sept 2007 - Apr 2012

  • Senior Manager | Strategic Planning | Marketing | R&D | Cardiac Operating Unit

    Nov 2001 - Sept 2007

  • Manager | Strategic Planning & Business Development | Global Marketing | Cardiac Operating Unit

    Feb 2000 - Nov 2001
• 

  DeFoe and Co LLC

  Jun 2023 - Apr 2024

  Founder & President

  Medical technology and healthcare consulting services including technology transfer, opportunity assessment and portfolio management, regulatory requirement and clinical evidence specialist, translational medicine, competitive benchmarking and market strategy, strategic planning, R&D roadmaps including AI, Machine Learning, Virtual and augmented reality, and robotics.

• 

  Solventum

  May 2024 - now

  R&D Strategic Growth Initiatives Director

  Responsible for driving enterprise growth strategies, managing the commercialization process, and building strategic external partnerships to foster innovation and success. Key responsibilities include:• Leading the strategic planning process for Research and Development, establishing a framework for strategic portfolio roadmaps.• Igniting front-end innovation by improving people, processes, and tools while leading pilot projects across various business units to strengthen the product pipeline and accelerate growth.• Championing an agile innovation culture focused on addressing unmet medical needs, improving patient outcomes, and advancing healthcare through better, safer, and smarter solutions.• Leveraging advanced innovation science, customer insights, and commercialization practices to deliver impactful results, utilizing both qualitative and quantitative methodologies while collaborating with global teams.• Strengthening the new product introduction process by enhancing systems, including governance frameworks and reporting metrics, to improve operational efficiency and adaptability. Show less